Financial results for the quarter ended on 30 June 2026
As filed · Press Release
EarningsMajormateriality 75 out of 100
What happened
FactFinancial results for the quarter ended on 30 June 2026.
Why it matters
CapitSignal interpretationReported results are the point at which prior management commitments become checkable against audited or reviewed numbers.
What management said before
Prior statements by this company that CapitSignal has recorded changing.
Demand
WithdrawnEarlierQ1 FY27
We are already in discussions with several large pharmaceutical companies and hope to transition at least two large pharmaceutical customers to integrated models this year.
NowQ1 FY27
We are seeing molecules transition through different stages of development.
Change
FactGuidance withdrawn
Implication
CapitSignal interpretationThe earlier statement mentioned transitioning at least two large pharmaceutical customers to integrated models, while the current statement does not mention this target.confidence 90%
Watch next
Fact- Margin trend against the prior period
- Cash from operations against reported profit
- Whether prior guidance is reaffirmed
- We are already in discussions with several large pharmaceutical companies and hope to transition at least two (management committed by FY27)
Evidence
How CapitSignal classified this
- Reasoning:
- RESULTS base 68; +2 corroborating keywords; +5 quantified amount; matched on subject
- Matched on:
- the filing's own subject line
- Confidence in the event type:
- 90%